Mission
Make Every Pharma
Company an AI Company™
Vision
Make Undruggable Targets a Thing of the Past™
Our ITO™ platform integrates massive multimodal data, frontier AI models, and high-throughput lab automation to deliver better small and large molecule drugs faster than traditional approaches.
1
The Problem
Pharmaceutical R&D productivity has been on a steady decline for decades. It costs $2.5B+ and takes 12–15 years to develop a single drug with <10% probability of success from Phase I clinical trials.
2
The Opportunity
AI and ML have the potential to reverse declining pharmaceutical R&D productivity and deliver better drugs to patients faster.
3
The Barriers
To fully realize the promise of AI in drug discovery and development, the Biopharma industry must overcome barriers in data scarcity, AI model training, computing power, and wet lab validation.
4
The Solution
Our ITO™ platform overcomes the data, model, computing, and wet lab validation barriers that prevent AI from achieving its full potential in drug discovery and development.
